首页|血液灌注联合血液透析治疗慢性肾衰竭尿毒症期患者疗效观察

血液灌注联合血液透析治疗慢性肾衰竭尿毒症期患者疗效观察

扫码查看
目的 探究血液灌注联合血液透析对慢性肾衰竭/尿毒症期患者脂质代谢、炎症状态、肾纤维化指标及骨代谢的影响,为临床治疗该种病症提供借鉴。方法 回顾性分析2021年12月-2022年12月来焦作市第二人民医院就诊的130例慢性肾衰竭/尿毒症期患者资料,根据治疗方法分为对照组(71例)、研究组(59例),其中对照组采用单纯血液透析,研究组采用血液灌注联合血液透析治疗。比较两组患者治疗前与治疗后6个月的脂质代谢情况、炎症情况、肾纤维化情况、骨代谢情况。结果 结果显示,研究组的血清总胆固醇(total cholesterol,TC)、三酰甘油(triglyceride,TG)、和骨形态发生蛋白(bone morphogenetic protein,BMP)、C 反应蛋白(C reactive protein,CRP)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、Ⅳ 型胶原(collage typeⅥ,Ⅵ-Col)、层粘连蛋白(laminin,LN)、Ⅲ型前胶原N 端肽(class Ⅲ procollagen N peptide,P Ⅲ P)、血骨钙素(bone gla protein,BGP)、成纤维细胞生长因子-23(fibroblast growth factor-23,FGF-23)、骨保护素(osteoclastogenesis inhibitory factor,OPG)水平均小于对照组,差异有统计学意义(P<0。05)。结论 血液灌注联合血液透析缓解慢性肾衰竭/尿毒症期患者的脂质代谢紊乱、炎症状态、肾纤维化进程和骨代谢异常,血液灌注联合血液透析的治疗效果较单纯血液透析更好。
Effect of blood perfusion combined with hemodialysis in treatment of uremia patients with chronic renal failure
Objective To explore the effect of blood perfusion combined with hemodialysis on lipid metabolism,inflam-matory status,renal fibrosis index,and bone metabolism in uremia patients with chronic renal failure.Methods The da-ta of 130 uremia patients with chronic renal failure in our hospital from December 2021 to December 2022 were retro-spectively analyzed and divided intocontrol group(71 people)and study group(59 people).Control group was given blood perfusion and study group was given blood perfusion combined with hemodialysis.The lipid metabolism,inflamma-tion,renal fibrosis,and bone metabolism of the two groups were compared before and 6 months after treatment.Results After six months treatment,the total cholesterol(total cholesterol,TC),triglyceride(TG),bone morphogenetic protein(BMP),and C-reactive protein(CRP),tumor necrosis factor-α(TNF-α),collagen type Ⅳ(Collage TypeⅥ,Ⅵ-Col),laminin(LN),N-terminal type Ⅲ procollagen Peptides(Class Ⅲ procollagen N peptide,P Ⅲ P),blood osteocalcin(Bone gla protein,BGP),fibroblast growth factor-23(fibroblast growth factor-23,FGF-23),and ostco-protegerin(osteoclastogenesis inhibitory factor,OPG)levels of study group were lower than those of control group,and the difference was statistically significant(P<0.05).Conclusion The combination of blood perfusion and hemodialysis alleviates lipid metabolism disorders,inflammatory status,renal fibrosis progression,and abnormal bone metabolism in pa-tients with chronic renal failure/uremia.The therapeutic effect of blood perfusion combined with hemodialysis is better than that of simple hemodialysis.

Blood perfusionHemodialysisChronic renal failure/uremic phaseLipid metabolismInflammatory state

王杰、刘伟、王霞、李燕燕

展开 >

焦作市第二人民医院肾内科,河南焦作 454000

焦作市第二人民医院检验科,河南焦作 454000

焦作市第二人民医院甲乳科,河南焦作 454000

血液灌注 血液透析 慢性肾衰竭/尿毒症期 脂质代谢 炎症状态

河南省医学科技攻关计划联合共建项目

LHGJ20230909

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(13)
  • 15